Avis Budget Group has received CEO Cancer Gold Standard™ accreditation, recognizing the Company’s commitment to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members.
Christopher A. Viehbacher chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than two million employees and family members are benefiting from the vision and leadership of Gold Standard employers.
“CEO Cancer Gold Standard acknowledges the leadership of Chairman and Chief Executive Officer Ronald L. Nelson and his commitment to the well-being of Avis Budget Group employees and their families,” said Christopher A. Viehbacher, CEO of Sanofi.
The CEO Cancer Gold Standard™ calls for employers to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encourage physical activity; promote healthy diet and nutrition; eliminate barriers under its benefits program for the early detection of cancer; and provide access to quality care, including participation in clinical trials.
Avis Budget Group was supported in its bid for Gold Standard accreditation by the American Cancer Society. The American Cancer Society home office is also a Gold Standard accredited workplace and the organization has encouraged other employers, large and small, to become Gold Standard accredited as well. Avis Budget Chairman and Chief Executive Officer Ronald L. Nelson received the 2011 Donald A. Gemson Cancer Prevention Public Policy Award from the American Cancer Society Cancer Action Network (ACS CAN) earlier this year.